| ²é¿´: 2677 | »Ø¸´: 35 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
zhaoguodong½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
¡¾ÌÖÂÛ¡¿ÀíÂÛ¼ÆËã³ö·ÔÚÄÄÀï°¡£¿
|
||
|
ÀíÂÛ¼ÆËã³ö·ÔÚÄÄÀï°¡£¿ ¼ÆË㾿¾¹ÄÜÓÐʲôÓô¦£¬Äܽâ¾öʲôÎÊÌ⣿ ÎÒÏÖÔÚºÜÃÔ㣬ϣÍû¸÷λָµãÃÔ½ò [ Last edited by csfn on 2008-1-31 at 10:27 ] |
» ²ÂÄãϲ»¶
¸ßЧ΢ÄÉÃ×´¢ÄܲÄÁÏÓë²úÒµ»¯ÍƽøÊµÑéÊÒ ËÕÖÝ ÕÐÊÕ˶ʿÑо¿Éú£¨º¬µ÷¼Á£©
ÒѾÓÐ0È˻ظ´
¼ªÁÖ¹¤³Ì¼¼Êõʦ·¶Ñ§Ôº ²ÄÁÏÓ뻯¹¤ £¨0856£© ÕÐÊÕµ÷¼Á
ÒѾÓÐ5È˻ظ´
ÎïÀí»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ182È˻ظ´
¹ú¼Ò´óÈ˲ſÎÌâ×éÕÐÊÕ»¯Ñ§¡¢²ÄÁÏ»¯¹¤Àà2026Äêµ÷¼ÁÉú
ÒѾÓÐ0È˻ظ´
¹ú¼Ò´óÈ˲ſÎÌâ×éÕÐÊÕ»¯Ñ§¡¢²ÄÁÏ»¯¹¤Àà2026Äêµ÷¼ÁÉú
ÒѾÓÐ0È˻ظ´
¼ªÁÖ¹¤³Ì¼¼Êõʦ·¶Ñ§Ôº ½»²æÑ§¿ÆÑо¿Ôº£¨08/07£© ÕÐÊÕµ÷¼Á
ÒѾÓÐ4È˻ظ´
¹ú¼Ò´óÈ˲ſÎÌâ×éÕÐÊÕ»¯Ñ§¡¢²ÄÁÏ»¯¹¤Àà2026Äêµ÷¼ÁÉú
ÒѾÓÐ0È˻ظ´
ËÕÖݿƼ¼´óѧ ÎïÀíѧרҵ ½ÓÊÕµ÷¼Á
ÒѾÓÐ0È˻ظ´
ËÕÖݿƼ¼´óѧ ÎïÀíѧרҵ ½ÓÊÕµ÷¼ÁÉú
ÒѾÓÐ20È˻ظ´
¹óÖÝ´óѧ2026Äê˶ʿÑо¿ÉúÕÐÉúµ÷¼Áȱ¶îÐÅÏ¢
ÒѾÓÐ3È˻ظ´
ºÓÄÏÀí¹¤´óѧ»¯Ñ§»¯¹¤Ñ§ÔºÕÐÊÕ˶ʿµ÷¼ÁÉú2Ãû
ÒѾÓÐ0È˻ظ´
yalefield
½ð³æ (ÎÄ̳¾«Ó¢)
ÀϺºÒ»Ã¶
- QCÇ¿Ìû: 1
- Ó¦Öú: 129 (¸ßÖÐÉú)
- ¹ó±ö: 0.17
- ½ð±Ò: 21238.9
- É¢½ð: 3440
- ºì»¨: 66
- Ìû×Ó: 12101
- ÔÚÏß: 759.1Сʱ
- ³æºÅ: 96063
- ×¢²á: 2005-10-07
- רҵ: ¸ßµÈ½ÌÓýѧ
- ¹ÜϽ: ¼ÆËãÄ£Äâ
¡ï
zzgyb(½ð±Ò+1,VIP+0):ллÄú²ÎÓëÌÖÂÛ£¬»¶ÓÄú³£À´¼ÆËãÄ£Äâ°æ¡£
zzgyb(½ð±Ò+1,VIP+0):ллÄú²ÎÓëÌÖÂÛ£¬»¶ÓÄú³£À´¼ÆËãÄ£Äâ°æ¡£
|
³É¶¼µÏÀ¿Ë¿ÆÑ§¼ÆËãÈí¼þÓÐÏÞÔðÈι«Ë¾ Dirac Scientific Computing LLC ÍõÏÈÁú ²©Ê¿ ×ܾÀí Vincent Wang, Ph.D. CEO, ³É¶¼¸ßÐÂÇø¸ßÅó´óµÀ21ºÅ£¬Óʱࣺ610041 µç»°£º(028) 85 333 112/3 Email £ºinfo@dirac.cn, Sachet.Dirac@gmail.com ÐéλÒÔ´ý£º 2¸öPh.D. Qualifications: - A PhD in computational chemistry, cheminformatics, molecular odeling/simulation, computational biology or other related disciplines. - Proved experience in at least one of these areas: structure-based drug design, virtual screening, docking, de novo design, molecular dynamics simulation, ligand-based drug-design, QSAR, cheminformatics, machine learning technology, force field, etc - Scripting and programming abilities - Strong oral and written English skills - Good communication skills and team-work spirit - Experience in industrial environment is a nice plus For consideration, please send your CV including publications, thesis topic, research summary to us: (1) info@dirac.cn (2) dirac.cn@gmail.com ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Welcome to Dirac Dirac Scientific Computing LLC is an emergent provider of in-silico solutions for drug discovery, life sciences research and material design. With expert service and experienced IT teams, DIRAC is capable of providing professional services and state-of-the-art IT products for researchers in molecule-related areas. DIRAC solutions benefit both industrial and academic fields. Scientific Computing Services and Products In addressing key challenges encountered by pharmaceutical and material enterprises, in-silicodesign solutions turn to be an extremely powerful tool. DIRAC offers contract research services and professional IT services to promote the use of the latest computing technology advancements in your research and development. Contract Research Services DIRAC provides customers professional services to resolve scientific computing problems in pharmaceutical R&D. Our on-site and off-site services can be embedded seamlessly into customer¡¯s whole R&D process. Virtual screening; Ligand-based Drug design; Structure-based drug design; Fragment-based drug discovery, ADMET prediction, descriptor construction, 3D-QSAR analysis, pharmacophore establishment, homology modeling, etc. Professional IT Services With an experienced IT team in coordination with an expert service team with specific knowledge in many disciplines, DIRAC is capable of understanding client¡¯s ideas precisely, and producing state-of-the-art IT solutions or software packages to fit the unique needs of our clients perfectly, e.g. scientific software development and testing, parallelization, databank building, data mining and custom data flow system. How we are different Exceptional Combination. Our team members come from various disciplines including mathematics, biology, chemistry, computer science etc. Creative and Innovative Ability. We apply cutting-edge knowledge and industry-leading technologies in building novel tools to address key challenges in pharmaceutical R&D. Small Size, Flexible and Adaptive Capability. The small size of the company enables us to easily provide best-fit solutions to match your unique requirements. Meaningful Impact. DIRAC¡¯s scientists have made contributions to dozens of peer-reviewed scientific papers. 1st in China, one of the fastest-developing countries in the world. |
30Â¥2008-01-30 17:05:47
yalefield
½ð³æ (ÎÄ̳¾«Ó¢)
ÀϺºÒ»Ã¶
- QCÇ¿Ìû: 1
- Ó¦Öú: 129 (¸ßÖÐÉú)
- ¹ó±ö: 0.17
- ½ð±Ò: 21238.9
- É¢½ð: 3440
- ºì»¨: 66
- Ìû×Ó: 12101
- ÔÚÏß: 759.1Сʱ
- ³æºÅ: 96063
- ×¢²á: 2005-10-07
- רҵ: ¸ßµÈ½ÌÓýѧ
- ¹ÜϽ: ¼ÆËãÄ£Äâ
¡ï
zzgyb(½ð±Ò+1,VIP+0):±ÈÓ÷²»´í£¬¾ÍÊÇÓе㲻ÊʺÏ
zzgyb(½ð±Ò+1,VIP+0):±ÈÓ÷²»´í£¬¾ÍÊÇÓе㲻ÊʺÏ
|
µ±ÎÒÊÖÀïÖ»Óм¸°ÙÔªµÄʱºò£¬ÎÒ×Ô¼ºÊÇÀí²Æ×¨¼Ò£» µ±ÎÒÊÖÀïÖ»Óм¸Ç§ÔªµÄʱºò£¬ÎÒÀÏÆÅÊÇÀí²Æ×¨¼Ò£» µ±ÎÒÊÖÀïÖ»Óм¸ÍòÔªµÄʱºò£¬ÎÒÔÀĸÊÇÀí²Æ×¨¼Ò...... µ±ÎÒÊÖÀïÖ»Óм¸ÒÚÔªµÄʱºò£¬ÎÒ»¹ÊÇÏ£Íû×Ô¼ºÊÇÀí²Æ×¨¼Ò£»¿ÉÊÇ£¬ËýÃDz»ÈÃÎÒµ±...... ²»¾Ã£¬ÎÒÊÖÀïÓÖÖ»Óм¸°ÙÔªÁË£¬µ«ÊÇÎÒÖÕÓÚµ±ÉÏÁËÀí²Æ×¨¼Ò¡£ |
2Â¥2007-09-30 16:56:04
ÍõТÊË
½ð³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1167.6
- Ìû×Ó: 1323
- ÔÚÏß: 1.4Сʱ
- ³æºÅ: 292898
- ×¢²á: 2006-11-04
- ÐÔ±ð: GG

4Â¥2007-09-30 17:46:39
sxzhu
½ð³æ (ÕýʽдÊÖ)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1244
- Ìû×Ó: 313
- ÔÚÏß: 2.1Сʱ
- ³æºÅ: 425816
- ×¢²á: 2007-07-28
- ÐÔ±ð: MM
- רҵ: ¼ÆË㻯ѧ
¡ï
zzgyb(½ð±Ò+1,VIP+0):¡°·ë¹®¡±Ð¡ÃÃÃÃÒ²À´ÁË£¬³¡ÃæÈÈÄÖÁË
zzgyb(½ð±Ò+1,VIP+0):¡°·ë¹®¡±Ð¡ÃÃÃÃÒ²À´ÁË£¬³¡ÃæÈÈÄÖÁË
|
ºÇºÇ£¬Ôںη½£¿»¯Ñ§ÖеļÆËã»ú¸ßÊÖ£¬¼ÆËã»úÖеĻ¯Ñ§¸ßÊÖ£¡£¡£¡ [ Last edited by sxzhu on 2007-9-30 at 20:31 ] |
5Â¥2007-09-30 20:29:42













»Ø¸´´ËÂ¥